Immunogen (IMGN)

Create an Alert
16.38 +0.37  +2.31%   NASDAQ Jun 18, 5:00PM BATS Real time Currency in USD

Immunogen Shareholders Equity:

139.00M for March 31, 2013
View Full Chart

Immunogen Shareholders Equity Chart

    Immunogen Historical Shareholders Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 139.00M
    Dec. 31, 2012 136.00M
    Sept. 30, 2012 157.31M
    June 30, 2012 83.89M
    March 31, 2012 100.93M
    Dec. 31, 2011 115.34M
    Sept. 30, 2011 123.77M
    June 30, 2011 139.97M
    March 31, 2011 64.82M
    Dec. 31, 2010 78.18M
    Sept. 30, 2010 90.52M
    June 30, 2010 102.05M
    March 31, 2010 35.95M
    Dec. 31, 2009 46.32M
    Sept. 30, 2009 56.35M
    June 30, 2009 66.86M
    March 31, 2009 38.03M
    Dec. 31, 2008 41.17M
    Sept. 30, 2008 47.36M
    June 30, 2008 55.30M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Shareholders' Equity

    Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
    Learn More

    Get data for

    IMGN Shareholders Equity Benchmarks

    Companies
    Seattle Genetics 233.27M
    Achillion Pharmaceuticals 195.00M
    GTx 36.06M

    IMGN Shareholders Equity Rankings

    Overall 70th percentile
    4948 of 16773
    Sector 77th percentile
    317 of 1408 in Healthcare
    Industry 86th percentile
    61 of 453 in Biotechnology

    IMGN Shareholders Equity Range, Past 5 Years

    Minimum 35.95M Mar 2010
    Maximum 157.31M Sep 2012
    Average 85.96M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');